NRX Pharmaceuticals (B1Q.F) Q3 2025 Earnings

18AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.84
-0.6
-0.37
-0.13

Details

Expected EPS
-0.128735607
Actual EPS
-0.8402324
Surprise EPS
-0.71
Surprise Percent
+552.68%

Description

NRX Pharmaceuticals (B1Q.F) has reported earnings of -0.8402324 per share for Q3 2025.

0 Comments

Share your thoughts